Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3746]

Immune-based treatment gets a boost to its cancer-fighting superpowers

Immune-based treatment gets a boost to its cancer-fighting superpowers

Clinic researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy

Clinic researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy

Timing matters when adding immunotherapy to chemoradiation for patients with limited-stage small cell lung cancer

Timing matters when adding immunotherapy to chemoradiation for patients with limited-stage small cell lung cancer

Existing standard chemoradiation superior to deintensification approaches for HPV-related oropharyngeal cancer

Existing standard chemoradiation superior to deintensification approaches for HPV-related oropharyngeal cancer

CAR-T safe and effective on an outpatient basis in community hospitals

CAR-T safe and effective on an outpatient basis in community hospitals

Leading-edge radiotherapy treatments for people with lung, genitourinary and blood cancers presented at the American Society for Radiation Oncology Annual Meeting

Leading-edge radiotherapy treatments for people with lung, genitourinary and blood cancers presented at the...

Trial supports radiotherapy and cisplatin should remain the standard of care for p16+ oropharyngeal cancer

Trial supports radiotherapy and cisplatin should remain the standard of care for p16+ oropharyngeal cancer

Oestrogens play a hidden role in cancers, inhibiting a key immune cell

Oestrogens play a hidden role in cancers, inhibiting a key immune cell

Unexpected immune response may hold key to long-term cancer remission

Unexpected immune response may hold key to long-term cancer remission

FDA approves isatuximab-irfc with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma

FDA approves isatuximab-irfc with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma

More from ecancer